Research
Research collaboration: International Cancer Genome Consortium (ICGC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
International Cancer Genome Consortium (ICGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Cancer Research UK (CRUK)
- Carlos Slim Health Institute
- Chinese Cancer Genome Consortium (CCGC)
- Department of Biotechnology (DBT)
- FP7 - Finland, EC
- French National Cancer Institute (INCa)
- Genome Canada
- German Aerospace Center (DLR)
- German Cancer Aid (DKH)
- German Federal Ministry of Education and Research (BMBF)
- Japan Agency for Medical Research and Development (AMED)
- King Faisal Specialist Hospital and Research Centre (KFSH&RC)
- Korea Research Institute of Bioscience and Biotechnology (KRIBB)
- NIH National Cancer Institute (NCI)
- NIH National Human Genome Research Institute (NHGRI)
- National Cancer Center (NCC)
- National Health and Medical Research Council (NHMRC)
- Ontario Institute for Cancer Research (OICR)
- Prostate Cancer Canada (PCC)
- Spain Ministry of Science, Innovation and Universities (MICINN)
- University of Glasgow
- University of Verona (UNIVR)
- Wellcome Sanger Institute
- Wellcome Trust
Affiliated joint institutions and consortia
Represents joint institutions and consortia for which the institution is designated as a partner institution. Each partner institution of a joint institution or consortium receives an equivalent Share for every affiliation in which the consortium is included.
Nature Strategy Reports
Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.
-
Actionable insights into research performance.
-
Detailed analysis of strengths and weaknesses.
-
Covers all major disciplines and regions of the world.